Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. The investment firm said it believes CVS (NYSE:CVS) will improve its ...
Deutsche Bank upgraded CVS to "buy" and maintained its $66 target price Shares of healthcare giant CVS Health Corp (NYSE:CVS) are 1.5% higher before the bell, after a bull note at Deutsche Bank. The ...
CVS Health (NYSE: CVS) is a big name in healthcare, and it has generally been seen as a good way to invest in the industry. In addition to its pharmacy retail operations, the company has a pharmacy ...
Shares of healthcare giant CVS Health (NYSE: CVS) have been in a free fall this year. The company has failed to impress investors with its earnings numbers and has slashed its guidance multiple times.
NEW YORK -- CVS will buy insurance giant Aetna in a roughly $69 billion deal that will help the drugstore chain reach deeper into customer health care and protect a key client, the companies announced ...
CVS Health (NYSE:CVS) is scheduled to announce its earnings on Thursday, July 31, 2025. For event-driven traders, analyzing the stock's historical behavior around earnings releases can provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results